Summary
If a patient gets a bedsore, who pays for it? Most importantly, what does this mean to KCI and the other wound companies? Where will it end?
Analysis
Regarding specifically pressure sores. If a patient needs a VAC type device, will there be reimbursement by CMS to Blue Sky, KCI and others?
If KCI elects to not bid on CMS patients, that is a good thing then. How about the others. They have difficulty breaking into the market -- will this hurt them with their bottom line reimbursement after they do break in? What about the patient? I am not sure how this could effect them.
Add to this, the hospital will have to eat the cost of the problems. Does that mean that they will not get reimbursement from CMS for pressure relief beds? I think that this decision by CMS will have many implications for patient care that have not been seen yet.


